✦ LIBER ✦

Primary End Point (Six Months) Results of the Ranibizumab for Edema of the mAcula in Diabetes (READ-2) Study

✍ Scribed by Quan Dong Nguyen; Syed Mahmood Shah; Jeffery S. Heier; Diana V. Do; Jennifer Lim; David Boyer; Prema Abraham; Peter A. Campochiaro

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Two-Year Outcomes of the Ranibizumab for

✍ Quan Dong Nguyen; Syed Mahmood Shah; Afsheen A. Khwaja; Roomasa Channa; Elham Ha 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 686 KB

Ranibizumab for Macular Edema following

✍ Peter A. Campochiaro; Jeffrey S. Heier; Leonard Feiner; Sarah Gray; Namrata Saro 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 663 KB

Ranibizumab for Macular Edema following

✍ David M. Brown; Peter A. Campochiaro; Rishi P. Singh; Zhengrong Li; Sarah Gray; 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 647 KB

Ranibizumab for edema of the macula in d

✍ Do, Diana V. (author);Nguyen, Quan D. (author);Khwaja, Afsheen A. (author);Chann 📂 Article 📅 2013 🏛 American Medical Association 🌐 English ⚖ 267 KB

Ranibizumab for edema of the macula in d

✍ Do, Diana V. (author);Nguyen, Quan D. (author);Khwaja, Afsheen A. (author);Chann 📂 Article 📅 2013 🏛 American Medical Association 🌐 English ⚖ 267 KB

The DA VINCI Study: Phase 2 Primary Resu

✍ Diana V. Do; Ursula Schmidt-Erfurth; Victor H. Gonzalez; Carmelina M. Gordon; Mi 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 745 KB